OPKO Health, Inc.
(NASDAQ : OPK)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.00%205.101.2%$477.70m
GILDGilead Sciences, Inc.
0.91%75.510.9%$401.46m
BIIBBiogen Inc.
1.22%345.411.3%$352.23m
CELGCelgene Corporation
-0.66%87.721.2%$341.18m
ILMNIllumina, Inc.
0.52%358.163.5%$248.76m
REGNRegeneron Pharmaceuticals, Inc.
0.78%390.282.6%$232.51m
VRTXVertex Pharmaceuticals Incorporated
-0.24%180.081.9%$168.98m
EXASExact Sciences Corporation
1.72%76.2825.3%$162.68m
SRPTSarepta Therapeutics, Inc.
-3.43%147.5916.4%$129.44m
AAgilent Technologies, Inc.
-0.58%70.721.5%$124.93m
VKTXViking Therapeutics, Inc.
-4.06%18.200.9%$115.92m
ALXNAlexion Pharmaceuticals, Inc.
-2.10%121.992.0%$114.40m
NKTRNektar Therapeutics
0.96%59.005.6%$106.74m
BMRNBioMarin Pharmaceutical Inc.
-2.55%97.844.4%$97.41m
ALNYAlnylam Pharmaceuticals, Inc
-0.67%94.579.7%$93.14m

Company Profile

OPKO Health, Inc. engages in the provision of healthcare services. It operates through the Diagnostics and Pharmaceuticals segments. The Diagnostics segment comprises clinical laboratory operations which acquired through the Bio-Reference and point-of-care operations. The Pharmaceuticals segment includes the pharmaceutical operations acquired in Chile, Mexico, Ireland, Israel, and Spain; and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.